Jiangsu Yahong Meditech Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 18, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,758,484 | Base addition salts of nitroxoline and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,324,739 | Combinational Uses of Nitroxoline and Its Analogues with Chemotherapies and Immunotherapies in the Treatment of Cancers In force · High confidence | In force | High confidence | |
| US 11,185,542 | Uses of dopamine beta-hydroxylase (DBH) inhibitors and serotonin receptor (5-HT) antagonists for the treatment of cancer In force · From the USPTO record | In force | From the USPTO record | |
| US 12,171,754 | Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers In force · From the USPTO record | In force | From the USPTO record | |
| US 12,310,960 | Combinational Uses of Nitroxoline and Its Analogues with Chemotherapies and Immunotherapies in the Treatment of Cancers In force · High confidence | In force | High confidence | |
| US 12,152,048 | Nitroxoline Prodrug and Use Thereof In force · High confidence | In force | High confidence | |
| US 12,583,835 | Crystal Form of Nitroxoline Prodrug, Pharmaceutical Composition Containing Same, and Preparation Method Therefor and Application Thereof In force · High confidence | In force | High confidence | |
| US 12,503,440 | Nitroxoline derivative, preparation method therefor, and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,502,384 | Pharmaceutical composition containing nitroxoline prodrug, and preparation method and application therefor In force · From the USPTO record | In force | From the USPTO record | |
| US 12,653,818 | Pharmaceutical Compositions Comprising Nitroxoline Lysinate, Preparation Method Therefor and Use Thereof In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
8 pending · 1 abandoned